Japan Tobacco receives Japanese manufacturing and marketing approval for Genvoya June 20, 2016 No Comments
Interim results show Frontier's phase III trial of albuvirtide for HIV meets primary objective June 6, 2016 No Comments
Theratechnologies presents preliminary primary endpoint results from phase III ibalizumab trial May 25, 2016 No Comments
NIH-funded phase IIb/III trial to evaluate HIV vaccine regimen in South Africa May 20, 2016 No Comments
RSS